CVS to sell $3.5B of senior notes

WOONSOCKET – CVS Health Corp. last week entered into an agreement to sell $3.5 billion of senior notes.
The deal, made with Barclays Capital Inc. and Merrill Lynch, Pierce, Fenner & Smith Inc., included an agreement for CVS to sell $1.7 billion aggregate principal amount of its 2.125 percent senior notes to the underwriters due June 1, 2021, according to a federal filing. An addition $1.7 billion aggregate principal amount of the company’s 2.875 percent senior notes were sold due June 1 2026.
The closing is set for May 25.

No posts to display